Computational modelling approaches to vaccinology.

Excepting the Peripheral and Central Nervous Systems, the Immune System is the most complex of somatic systems in higher animals. This complexity manifests itself at many levels from the molecular to that of the whole organism. Much insight into this confounding complexity can be gained through computational simulation. Such simulations range in application from epitope prediction through to the modelling of vaccination strategies. In this review, we evaluate selectively various key applications relevant to computational vaccinology: these include technique that operates at different scale that is, from molecular to organisms and even to population level.

[1]  D. Flower,et al.  In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination , 2008, Proceedings of the National Academy of Sciences.

[2]  R. Fleischmann,et al.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. , 1995, Science.

[3]  Vladimir Brusic,et al.  Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research , 2008, BMC Bioinformatics.

[4]  D. Flower.  Systematic identification of small molecule adjuvants , 2012, Expert opinion on drug discovery.

[5]  Doron Levy,et al.  A Mathematical Model of the Enhancement of Tumor Vaccine Efficacy by Immunotherapy , 2012, Bulletin of mathematical biology.

[6]  M. Bianchi.  DAMPs, PAMPs and alarmins: all we need to know about danger , 2007, Journal of leukocyte biology.

[7]  Ferdinando Chiacchio,et al.  Mathematical modeling of the immune system recognition to mammary carcinoma antigen , 2012, BMC Bioinformatics.

[8]  R. Rappuoli.  Reverse vaccinology : Genomics , 2000 .

[9]  Uthaman Gowthaman,et al.  In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. , 2008, Journal of proteome research.

[10]  Piero Musiani,et al.  Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice , 2001, The Journal of experimental medicine.

[11]  Chang H. Kim.  Migration and function of Th17 cells. , 2009, Inflammation & allergy drug targets.

[12]  D. Levy,et al.  Applying Mathematical Tools to Accelerate Vaccine Development: Modeling Shigella Immune Dynamics , 2013, PloS one.

[13]  Channa K. Hattotuwagama,et al.  Receptor-ligand binding sites and virtual screening. , 2006, Current medicinal chemistry.

[14]  D. Flower,et al.  MHC Class I Bound to an Immunodominant Theileria parva Epitope Demonstrates Unconventional Presentation to T Cell Receptors , 2010, PLoS pathogens.

[15]  Li Zhang,et al.  Structure-Based Selection of Small Molecules To Alter Allele-Specific MHC Class II Antigen Presentation , 2011, The Journal of Immunology.

[16]  Filippo Castiglione,et al.  Vaccine protocols optimization: in silico experiences. , 2010, Biotechnology advances.

[17]  Francesco Pappalardo,et al.  Optimal vaccination schedules using simulated annealing , 2008, Bioinform..

[18]  Filippo Castiglione,et al.  Modeling and simulation of cancer immunoprevention vaccine , 2005, Bioinform..

[19]  D. Flower,et al.  From 'perfect mix' to 'potion magique' — regulatory T cells and anti-inflammatory cytokines as adjuvant targets , 2008, Nature Reviews Microbiology.

[20]  Filippo Castiglione,et al.  VaccImm: simulating peptide vaccination in cancer therapy , 2013, BMC Bioinformatics.

[21]  P. Musiani,et al.  Antimetastatic activity of a preventive cancer vaccine. , 2007, Cancer research.

[22]  William Martin,et al.  Epitope-Based Immunome-Derived Vaccines: A Strategy for Improved Design and Safety , 2008, Clinical Applications of Immunomics.

[23]  C DeLisi,et al.  T-cell antigenic sites tend to be amphipathic structures. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Bajorath,et al.  Quo vadis, virtual screening? A comprehensive survey of prospective applications. , 2010, Journal of medicinal chemistry.

[25]  Morten Nielsen,et al.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.

[26]  D. Flower,et al.  Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. , 2007, Vaccine.

[27]  F. Pappalardo,et al.  In silico modeling and in vivo efficacy of cancer-preventive vaccinations. , 2010, Cancer research.

[28]  Bernhard Knapp,et al.  A critical cross-validation of high throughput structural binding prediction methods for pMHC , 2009, J. Comput. Aided Mol. Des..

[29]  Vasant Honavar,et al.  On Evaluating MHC-II Binding Peptide Prediction Methods , 2008, PloS one.

[30]  D. Flower,et al.  Toward the Discovery of Vaccine Adjuvants: Coupling In Silico Screening and In Vitro Analysis of Antagonist Binding to Human and Mouse CCR4 Receptors , 2009, PloS one.

[31]  K Y Sanbonmatsu,et al.  High performance computing in biology: multimillion atom simulations of nanoscale systems. , 2007, Journal of structural biology.

[32]  Ying Xu,et al.  Limitations of Ab Initio Predictions of Peptide Binding to MHC Class II Molecules , 2010, PloS one.

[33]  Campbell McInnes,et al.  Virtual screening strategies in drug discovery. , 2007, Current opinion in chemical biology.

[34]  C. Bianca,et al.  The triplex vaccine effects in mammary carcinoma: A nonlinear model in tune with SimTriplex ☆ , 2012 .

[35]  P. Coveney,et al.  Toward an atomistic understanding of the immune synapse: large-scale molecular dynamics simulation of a membrane-embedded TCR-pMHC-CD4 complex. , 2008, Molecular immunology.

[36]  Peter P. Lee,et al.  Modeling Protective Anti-Tumor Immunity via Preventative Cancer Vaccines Using a Hybrid Agent-based and Delay Differential Equation Approach , 2012, PLoS Comput. Biol..

[37]  D. Flower,et al.  Benchmarking B cell epitope prediction: Underperformance of existing methods , 2005, Protein science : a publication of the Protein Society.

[38]  Francesco Topputo,et al.  Induction of T-cell memory by a dendritic cell vaccine: a computational model , 2014, Bioinform..

[39]  V. Brusic,et al.  Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design. , 2009, Molecular immunology.

[40]  W. Pichler,et al.  Etiology and pathogenesis of adverse drug reactions. , 2012, Chemical immunology and allergy.

[41]  Francesco Pappalardo,et al.  SimB16: Modeling Induced Immune System Response against B16-Melanoma , 2011, PloS one.

[42]  Rino Rappuoli,et al.  Reverse vaccinology. , 2000, Current opinion in microbiology.

[43]  D. Lauffenburger,et al.  Applying computational modeling to drug discovery and development. , 2006, Drug discovery today.

[44]  Francesco Filippini,et al.  NERVE: New Enhanced Reverse Vaccinology Environment , 2006, BMC biotechnology.

[45]  Irini A. Doytchinova,et al.  BMC Bioinformatics BioMed Central Methodology article VaxiJen: a server for prediction of protective antigens, tumour , 2007 .

[46]  Zinnia P. Parra-Guillen,et al.  Mathematical Model Approach to Describe Tumour Response in Mice After Vaccine Administration and its Applicability to Immune-Stimulatory Cytokine-Based Strategies , 2013, The AAPS Journal.

[47]  D. Hanahan,et al.  A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. , 2011, Blood.

[48]  M. Nielsen,et al.  NetMHCstab – predicting stability of peptide–MHC‐I complexes; impacts for cytotoxic T lymphocyte epitope discovery , 2014, Immunology.

[49]  Michael Price.  Computational Biologists: The Next Pharma Scientists? , 2012 .

[50]  Francesco Pappalardo,et al.  Genetic Algorithm Against Cancer , 2005, WILF.

[51]  Pedro A Reche,et al.  Prediction of MHC-peptide binding: a systematic and comprehensive overview. , 2009, Current pharmaceutical design.

[52]  O. Lund,et al.  NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ , 2013, Immunogenetics.

[53]  Peter V Coveney,et al.  T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges , 2010, Immunome research.

[54]  M. Aihara.  Pharmacogenetics of cutaneous adverse drug reactions , 2011, The Journal of dermatology.

[55]  Marzio Pennisi,et al.  A Mathematical Model of Immune-System-Melanoma Competition , 2012, Comput. Math. Methods Medicine.

[56]  Francesco Pappalardo,et al.  Modeling the competition between lung metastases and the immune system using agents , 2010, BMC Bioinformatics.

[57]  Badal Joshi,et al.  On immunotherapies and cancer vaccination protocols: a mathematical modelling approach. , 2009, Journal of theoretical biology.

[58]  A. Michels.  Targeting the trimolecular complex. , 2013, Clinical immunology.